Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 17
Healthy Volunteers: f
View:
• Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
• Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
• Between the ages of 4 and 17 years of age.
• Documented neurogenic bladder dysfunction
• On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial
Locations
United States
Pennsylvania
University of Pittsburgh
RECRUITING
Pittsburgh
Contact Information
Primary
Sydney Bader, MS
syb17@pitt.edu
412-648-4196
Time Frame
Start Date: 2026-06-10
Estimated Completion Date: 2029-03-10
Participants
Target number of participants: 20
Treatments
Experimental: Transcutaneous SCS
All participants will be receiving transcutaneous spinal cord stimulation
Related Therapeutic Areas
Sponsors
Leads: Bailey Petersen